Health Bulletin 16/October/2023 Isra Zaman16 Oct 2023 5:34 PM ISTHere are the Top Health stories for the day:Breakthrough Made-In-India CAR-T Cell therapy NexCAR19 gets DCGI nod for blood cancer...
EU medicines regulator recommends conditional marketing nod for Pfizer blood cancer therapy Ruchika Sharma15 Oct 2023 2:15 PM ISTNew York: The European Union medicines regulator has recommended a conditional marketing authorization for U.S. drugmaker Pfizer's therapy for a type...
Breakthrough Made-in-India CAR-T cell therapy NexCAR19 gets DCGI nod for blood cancer treatment Ruchika Sharma14 Oct 2023 1:30 PM ISTDr Satyanarayana Chava, Founder-CEO of Laurus says, "We are very happy and proud to be part of this indigenously developed Cell therapy product for...
Diabetes may accelerate growth of multiple myeloma yet survival outcomes differ by race Dr. Kamal Kant Kohli3 Oct 2023 8:00 PM ISTPatients with multiple myeloma, a blood cancer of plasma cells in the bone marrow, who also have diabetes have a reduced overall survival when...
AbbVie blood cancer combo therapy fails in late-stage study Ruchika Sharma2 Oct 2023 1:00 PM ISTUnited States: AbbVie has said a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully...
Bariatric surgery associated with Lower risk of haematological cancer among women: Lancet Dr. Kamal Kant Kohli27 Sept 2023 8:00 PM ISTPrevious studies have shown that overweight and obesity are risk factors for several types of cancer. It is also known that obese women have a higher...
Momelotinib receives FDA approval for patients of myelofibrosis with anaemia Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTUSA: JAK inhibitor momelotinib (Ojjaara) has received approval from the US Food and Drug Administration (FDA) as the first therapy specifically for...
Medical Bulletin 19/September/2023 Isra Zaman19 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Researchers uncover surprising side effects of common diabetes drug MetforminMetformin, a well-established...
FDA approves JAK inhibitor Momelotinib for Myelofibrosis in Anemic adults Isra Zaman19 Sept 2023 9:30 AM ISTThe US Food and Drug Administration (FDA) has approved momelotinib for the treatment of intermediate or high-risk myelofibrosis, including primary...
GSK gets USFDA nod for bone marrow cancer therapy Ojjaara Ruchika Sharma16 Sept 2023 11:54 AM ISTOjjaara is a once-a-day, oral JAK1/JAK2 and activin A receptor type 1 (ACVR1) inhibitor.
Bristol Myers Squibb accused of illegal tactics to keep blood cancer drug Pomalyst monopoly in lawsuit Ruchika Sharma7 Sept 2023 1:30 PM ISTBristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on...
Doctors at BHU perform first allogeneic stem cell transplant on 11-year-old child with acute lymphoblastic leukaemia Kajal Rajput3 Sept 2023 9:30 AM ISTVaranasi: Doctors at the Department of Paediatrics, IMS-BHU (Banaras Hindu University) have carried out the first allogeneic stem cell transplantation...
